Penicillamine and Memory loss - a phase IV clinical study of FDA data

Summary:

We study 1,299 people who have side effects when taking Penicillamine. Memory loss is found, especially among people who are female, 60+ old, also take Lyrica and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people take Penicillamine and have Memory loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

1,299 people reported to have side effects when taking Penicillamine.
Among them, 13 people (1.0%) have Memory loss.

What is Penicillamine?

Penicillamine has active ingredients of penicillamine. Currently, eHealthMe is studying from 1,299 Penicillamine users.

What is Memory loss?

Memory loss is found to be associated with 4,211 drugs and 4,279 conditions by eHealthMe. Currently, we are studying 231,910 people who have Memory loss.

Number of Penicillamine and Memory loss reports submitted per year:

Gender of people who have Memory loss when taking Penicillamine *:

female: 75 %
male: 25 %

Age of people who have Memory loss when taking Penicillamine *:

Common drugs people take besides Penicillamine *:

Common side effects people have besides Memory loss *:

Nausea (feeling of having an urge to vomit): 8 people, 61.54%
Hyperaesthesia: 7 people, 53.85%
Chills (felling of cold): 7 people, 53.85%
Constipation: 7 people, 53.85%
Dizziness: 7 people, 53.85%
Hypotension (abnormally low blood pressure): 7 people, 53.85%
Weakness: 7 people, 53.85%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 53.85%
Swelling: 7 people, 53.85%
High Blood Pressure: 7 people, 53.85%

Common conditions people have *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 61.54%
Pain: 7 people, 53.85%
High Blood Pressure: 7 people, 53.85%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 7 people, 53.85%
Gastric Disorder (disease of stomach): 7 people, 53.85%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 46.15%
Urination - Excessive Volume: 3 people, 23.08%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 7.69%
Pelvic Pain: 1 person, 7.69%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Penicillamine and have Memory loss?

Check whether Memory loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Penicillamine side effects by duration, gender and age:

Penicillamine side effects (1,299 reports)

Memory loss treatments and more:

Memory loss (231,910 reports)

Common drugs associated with Memory loss:

All the drugs that are associated with Memory loss:

Memory loss (4,211 drugs)

Common conditions associated with Memory loss:

All the conditions that are associated with Memory loss:

Memory loss (4,279 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on penicillamine (the active ingredients of Penicillamine) and Penicillamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.